View in EDS

Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.

Saved in:
Bibliographic Details
Title: Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.
Authors: Palomero J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Galvao V; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Creus I; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Lostes J; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Aylagas M; Banc de Sang i Teixits (Blood and Tissue Bank, BST), Barcelona, Spain., Marín-Bayo A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Rotxés M; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Sanz M; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Lozano-Rabella M; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Garcia-Garijo A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Yuste-Estevanez A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Grases D; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Díaz-Gómez J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., González J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Navarro JF; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Gartner JJ; Surgery Branch, National Cancer Institute, Bethesda, USA., Braña I; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Villalobos X; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Bayó-Puxan N; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Jiménez J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Palazón AN; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Muñoz S; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Villacampa G; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Piris-Giménez A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Barba P; Hematology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Codinach M; Banc de Sang i Teixits (Blood and Tissue Bank, BST), Barcelona, Spain.; Vall d'Hebron Research Institute-Autonomous University of Barcelona (VHIR-UAB), Barcelona., Rodríguez L; Banc de Sang i Teixits (Blood and Tissue Bank, BST), Barcelona, Spain., Querol S; Banc de Sang i Teixits (Blood and Tissue Bank, BST), Barcelona, Spain., Muñoz-Couselo E; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Tabernero J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.; Institute of Oncology (IOB)-Quirón, Barcelona-Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Vic-CIBER en oncología (CIBERONC) ISCIII, Madrid., Martín-Lluesma S; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.; Department of Basic Medical Sciences, Faculty of Medicine, University of Sant Pablo-CEU, CEU Universities, Madrid, Spain., Gros A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Garralda E; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.
Source: Immuno-oncology technology [Immunooncol Technol] 2024 Dec 02; Vol. 25, pp. 101030. Date of Electronic Publication: 2024 Dec 02 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9918281581106676 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-0188 (Electronic) Linking ISSN: 25900188 NLM ISO Abbreviation: Immunooncol Technol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39911162
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Palomero+J%22">Palomero J</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Galvao+V%22">Galvao V</searchLink>; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.<br /><searchLink fieldCode="AU" term="%22Creus+I%22">Creus I</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Lostes+J%22">Lostes J</searchLink>; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.<br /><searchLink fieldCode="AU" term="%22Aylagas+M%22">Aylagas M</searchLink>; Banc de Sang i Teixits (Blood and Tissue Bank, BST), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Marín-Bayo+A%22">Marín-Bayo A</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Rotxés+M%22">Rotxés M</searchLink>; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.<br /><searchLink fieldCode="AU" term="%22Sanz+M%22">Sanz M</searchLink>; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.<br /><searchLink fieldCode="AU" term="%22Lozano-Rabella+M%22">Lozano-Rabella M</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Garcia-Garijo+A%22">Garcia-Garijo A</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Yuste-Estevanez+A%22">Yuste-Estevanez A</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Grases+D%22">Grases D</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Díaz-Gómez+J%22">Díaz-Gómez J</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22González+J%22">González J</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Navarro+JF%22">Navarro JF</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Gartner+JJ%22">Gartner JJ</searchLink>; Surgery Branch, National Cancer Institute, Bethesda, USA.<br /><searchLink fieldCode="AU" term="%22Braña+I%22">Braña I</searchLink>; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.<br /><searchLink fieldCode="AU" term="%22Villalobos+X%22">Villalobos X</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Bayó-Puxan+N%22">Bayó-Puxan N</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Jiménez+J%22">Jiménez J</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Palazón+AN%22">Palazón AN</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Muñoz+S%22">Muñoz S</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Villacampa+G%22">Villacampa G</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Piris-Giménez+A%22">Piris-Giménez A</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Barba+P%22">Barba P</searchLink>; Hematology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.<br /><searchLink fieldCode="AU" term="%22Codinach+M%22">Codinach M</searchLink>; Banc de Sang i Teixits (Blood and Tissue Bank, BST), Barcelona, Spain.; Vall d'Hebron Research Institute-Autonomous University of Barcelona (VHIR-UAB), Barcelona.<br /><searchLink fieldCode="AU" term="%22Rodríguez+L%22">Rodríguez L</searchLink>; Banc de Sang i Teixits (Blood and Tissue Bank, BST), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Querol+S%22">Querol S</searchLink>; Banc de Sang i Teixits (Blood and Tissue Bank, BST), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Muñoz-Couselo+E%22">Muñoz-Couselo E</searchLink>; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.<br /><searchLink fieldCode="AU" term="%22Tabernero+J%22">Tabernero J</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.; Institute of Oncology (IOB)-Quirón, Barcelona-Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Vic-CIBER en oncología (CIBERONC) ISCIII, Madrid.<br /><searchLink fieldCode="AU" term="%22Martín-Lluesma+S%22">Martín-Lluesma S</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.; Department of Basic Medical Sciences, Faculty of Medicine, University of Sant Pablo-CEU, CEU Universities, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gros+A%22">Gros A</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.<br /><searchLink fieldCode="AU" term="%22Garralda+E%22">Garralda E</searchLink>; Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918281581106676%22">Immuno-oncology technology</searchLink> [Immunooncol Technol] 2024 Dec 02; Vol. 25, pp. 101030. <i>Date of Electronic Publication: </i>2024 Dec 02 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918281581106676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2590-0188 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225900188%22">25900188 </searchLink><i>NLM ISO Abbreviation: </i>Immunooncol Technol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39911162
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.iotech.2024.101030
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101030
    Titles:
      – TitleFull: Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Palomero J
      – PersonEntity:
          Name:
            NameFull: Galvao V
      – PersonEntity:
          Name:
            NameFull: Creus I
      – PersonEntity:
          Name:
            NameFull: Lostes J
      – PersonEntity:
          Name:
            NameFull: Aylagas M
      – PersonEntity:
          Name:
            NameFull: Marín-Bayo A
      – PersonEntity:
          Name:
            NameFull: Rotxés M
      – PersonEntity:
          Name:
            NameFull: Sanz M
      – PersonEntity:
          Name:
            NameFull: Lozano-Rabella M
      – PersonEntity:
          Name:
            NameFull: Garcia-Garijo A
      – PersonEntity:
          Name:
            NameFull: Yuste-Estevanez A
      – PersonEntity:
          Name:
            NameFull: Grases D
      – PersonEntity:
          Name:
            NameFull: Díaz-Gómez J
      – PersonEntity:
          Name:
            NameFull: González J
      – PersonEntity:
          Name:
            NameFull: Navarro JF
      – PersonEntity:
          Name:
            NameFull: Gartner JJ
      – PersonEntity:
          Name:
            NameFull: Braña I
      – PersonEntity:
          Name:
            NameFull: Villalobos X
      – PersonEntity:
          Name:
            NameFull: Bayó-Puxan N
      – PersonEntity:
          Name:
            NameFull: Jiménez J
      – PersonEntity:
          Name:
            NameFull: Palazón AN
      – PersonEntity:
          Name:
            NameFull: Muñoz S
      – PersonEntity:
          Name:
            NameFull: Villacampa G
      – PersonEntity:
          Name:
            NameFull: Piris-Giménez A
      – PersonEntity:
          Name:
            NameFull: Barba P
      – PersonEntity:
          Name:
            NameFull: Codinach M
      – PersonEntity:
          Name:
            NameFull: Rodríguez L
      – PersonEntity:
          Name:
            NameFull: Querol S
      – PersonEntity:
          Name:
            NameFull: Muñoz-Couselo E
      – PersonEntity:
          Name:
            NameFull: Tabernero J
      – PersonEntity:
          Name:
            NameFull: Martín-Lluesma S
      – PersonEntity:
          Name:
            NameFull: Gros A
      – PersonEntity:
          Name:
            NameFull: Garralda E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 12
              Text: 2024 Dec 02
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2590-0188
          Numbering:
            – Type: volume
              Value: 25
          Titles:
            – TitleFull: Immuno-oncology technology
              Type: main
ResultId 1